Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceutics
Hlavní autoři: Otto, Matthias, Krebs, Jörg, Welker, Peter, Holm, René, Thiel, Manfred, Gattinoni, Luciano, Quintel, Michael, Tsagogiorgas, Charalambos
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004724/
https://ncbi.nlm.nih.gov/pubmed/33806903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030431
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky